PROCEPT BioRobotics (PRCT) Income from Continuing Operations (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Income from Continuing Operations data on file, last reported at 31638000.0 in Q1 2026.

• On a quarterly basis, Income from Continuing Operations fell 27.9% year-over-year to 31638000.0 in Q1 2026; TTM through Mar 2026 was 185854000.0, a 65.81% decrease from a year earlier, with the FY2025 full-year figure at 95572000.0, down 4.55% from the prior year.
• Income from Continuing Operations for Q1 2026 stood at 31638000.0, up from 32646000.0 in the prior quarter.
• Over the last five years, Income from Continuing Operations for PRCT reached as high as 19316000.0 in Q2 2022 and fell as low as 77956000.0 in Q1 2023.
• Historically, Income from Continuing Operations has averaged 36745176.47 across 5 years, with a median of 31638000.0 in 2026.
• Across the five-year window, Income from Continuing Operations slumped 296.97% in 2023 and jumped 46.71% in 2024, its largest moves.
• Year by year, Income from Continuing Operations stood at 23972000.0 in 2022, then slipped by 27.99% to 30682000.0 in 2023, then surged by 32.64% to 20667000.0 in 2024, then tumbled by 57.96% to 32646000.0 in 2025, then climbed by 3.09% to 31638000.0 in 2026.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were 31638000.0 in Q1 2026, 32646000.0 in Q4 2025, and 60749000.0 in Q3 2025.